BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9215748)

  • 21. Induction of erythroid gene expression by microcell fusion.
    Kanamori H; Siegel JN
    Exp Cell Res; 1997 Apr; 232(1):90-6. PubMed ID: 9141625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture.
    Mahajan MC; Karmakar S; Newburger PE; Krause DS; Weissman SM
    Exp Hematol; 2009 Oct; 37(10):1143-1156.e3. PubMed ID: 19607874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
    Karacay B; Chang LS
    Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells.
    Sayer MS; Tilbrook PA; Spadaccini A; Ingley E; Sarna MK; Williams JH; Andrews NC; Klinken SP
    J Biol Chem; 2000 Aug; 275(33):25292-8. PubMed ID: 10842186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroid regulatory elements.
    Raich N; Romeo PH
    Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
    Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
    Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
    Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
    Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
    Szulawska A; Arkusinska J; Czyz M
    Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells.
    Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M
    Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell factor and interleukin-3 induce stepwise generation of erythroid precursor cells from a basic fibroblast growth factor-dependent hematopoietic stem cell line, A-6.
    Anzai H; Ikawa Y; Atsumi T
    Biochem Biophys Res Commun; 2001 Apr; 282(4):940-6. PubMed ID: 11352642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of glutamine enhances sodium butyrate-induced erythroid differentiation of K562 cells.
    Canh Hiep N; Kinohira S; Furuyama K; Taketani S
    J Biochem; 2012 Dec; 152(6):509-19. PubMed ID: 22923740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
    Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
    Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
    Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
    Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
    Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
    Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro transcription of erythroid promoters using baculoviral-expressed human GATA-1: purification, physicochemistry, and activities.
    Taxman DJ; Sonsteby SK; Wojchowski DM
    Protein Expr Purif; 1994 Dec; 5(6):587-94. PubMed ID: 7858429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.
    Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T
    Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear relocation of a transactivator subunit precedes target gene activation.
    Francastel C; Magis W; Groudine M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12120-5. PubMed ID: 11593025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to catechol in long term.
    Yu CH; Cui NX; Wang Y; Wang Y; Liu WJ; Gong M; Zhao X; Rong L; Yi ZC
    Toxicol In Vitro; 2017 Sep; 43():21-28. PubMed ID: 28552822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and nrf-2.
    Martin F; van Deursen JM; Shivdasani RA; Jackson CW; Troutman AG; Ney PA
    Blood; 1998 May; 91(9):3459-66. PubMed ID: 9558405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.